{"entities":{"Q9928":{"pageid":14089,"ns":120,"title":"Item:Q9928","lastrevid":207665,"modified":"2020-05-22T13:50:18Z","type":"item","id":"Q9928","labels":{"en":{"language":"en","value":"Moreb J, et al. Cancer Gene Ther. (1996) cited as Ref 665 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9928$EDE01522-23EB-4F34-86F9-53C1683F652B","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9928$237229C3-920A-4F5D-9B3F-00009C1C814F","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Moreb J","type":"string"},"datatype":"string"},"type":"statement","id":"Q9928$3E28BDF5-30E2-4A46-B055-A78146D78DC6","rank":"normal"}],"P150":[{"mainsnak":{"snaktype":"value","property":"P150","datavalue":{"value":"Schweder M","type":"string"},"datatype":"string"},"type":"statement","id":"Q9928$233A2D68-892D-4BBC-9256-89174ED70439","rank":"normal"}],"P151":[{"mainsnak":{"snaktype":"value","property":"P151","datavalue":{"value":"Suresh A","type":"string"},"datatype":"string"},"type":"statement","id":"Q9928$43DE5783-1833-4AD0-B64C-81D75BC86541","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"8785707","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9928$97445CE2-83D5-455B-A5FC-E6FF5E8AE726","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+1996-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9928$A664A6FC-0637-4955-87CB-36748B9FF46F","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Cancer Gene Ther.","type":"string"},"datatype":"string"},"type":"statement","id":"Q9928$489B13AC-8A90-4F8B-A58B-0187EDF04C65","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"3","type":"string"},"datatype":"string"},"type":"statement","id":"Q9928$FB0A76AF-5C32-402D-B2A8-47546B3BA4BD","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9928$0E49389A-2B48-4D6E-B1A4-5AD89ABD144B","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"24-30","type":"string"},"datatype":"string"},"type":"statement","id":"Q9928$67CB1959-C7A0-4C4B-8FD4-06CCFAE26FD8","rank":"normal"}],"P152":[{"mainsnak":{"snaktype":"value","property":"P152","datavalue":{"value":"Zucali JR","type":"string"},"datatype":"string"},"type":"statement","id":"Q9928$17EADC2B-8281-4981-83D6-B01467756B2E","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Moreb J, et al. Cancer Gene Ther. (1996) cited as Ref 665 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Moreb_J,_et_al._Cancer_Gene_Ther._(1996)_cited_as_Ref_665_in_DOI:_10.1038/s41392-020-0110-5"}}}}}